Become a Biotech Millionaire?

For your weekly reading, we bring you the week's most popular stories from Wealth Daily and our sister site, Energy and Capital... For your weekly reading, we bring you the week's most popular stories from Wealth Daily and our sister site, Energy and Capital. [Wealth Daily logo] Become a Biotech Millionaire? [Briton Ryle Photo] By [Briton Ryle]( Written Jul 15, 2020 For your weekly reading, we bring you the week's most popular stories from [Wealth Daily]( and our sister site, [Energy and Capital](... [Seeing the Good in the Bad]( As someone who enjoys making a profit, Wealth Daily editor Monica Savaglia likes focusing on what’s going to push her towards the light at the end of the tunnel when the world seems darker than ever. And right now that light is the $1.1 trillion biotech industry... [Investing in the Cure for Chronic Disease]( Right now, Energy and Capital editor Jeff Siegel is very bullish on a small biotech firm that’s currently conducting clinical trials on a new drug that looks like it could not only completely cure chronic diseases, but even reverse them... [How to Play Bitcoin Alongside Gold]( Bitcoin just broke through $9,000 again. But before you go jump on the bandwagon, know I’ve uncovered something so crazy, I’m worried that I might lose you. The numbers are real and the crypto loophole this exploits is completely legal. 99.99% of U.S. investors have NO idea it exists, but it could turn every $1,000 into $23,000 or more. [Investing in Anti-Aging Technology: The Holy Grail of Stock Picks?]( Advances in biotech could extend human life expectancy by hundreds of years, and investors can get in at the ground floor. Wealth Daily editor Jason Stutman explains how investors can take advantage of this once-in-a-lifetime opportunity... [The Central Bank Shell Game]( Central banks are looking in the face of the greatest economic downturn the world has ever seen. They are also buying gold in record numbers. Energy and Capital editor Christian DeHaemer explains the central bank shell game... [The Best 5G Stock You've Never Heard Of]( I’ve uncovered what could be the most promising stock in the 5G market. It’s a single play that will let you earn money from every single company in the 5G sector. This is your chance — this company is poised to go vertical. It's already inked contracts with some of the biggest media companies, like T-Mobile, Cox, Sprint, and dozens more. [Global Elite Declare War on Middle Class]( A war is being waged against you by the global elite. You can’t fight it, but you can protect yourself. Wealth Daily editor Jason Williams wants to help you survive the death of the middle class and thrive in the new world... [Gold Set to Break Records: But What About Silver?]( In the wake of COVID-19, gold has soared in popularity as an investment asset. But what about silver? Energy and Capital editor Luke Burgess compares gold and silver to one another, a comparison many feel is akin to apples and oranges... [Become a Biotech Millionaire?](For the first time ever, it’s possible for ANYONE to become a biotech millionaire. As long as you can do one very simple thing, you could be setup to clock huge cash payouts of $17,000 or more every month... six times a month. With money like that, you could be setup to be a millionaire in no time. Until next time, [brit''s sig] Briton Ryle [[follow basic]@BritonRyle on Twitter]( A 21-year veteran of the newsletter business, Briton Ryle is the editor of [The Wealth Advisory]( income stock newsletter, with a focus on top-quality dividend growth stocks and REITs. Briton also manages the [Real Income Trader]( advisory service, where his readers take regular cash payouts using a low-risk covered call option strategy. He also contributes a weekly column to the [Wealth Daily]( e-letter. To learn more about Briton, [click here.]( Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Is Uber Afraid of a DoorDash IPO?]( [Investing in Anti-Aging Technology: The Holy Grail of Stock Picks?]( [Global Elite Declare War on Middle Class]( [Another $1.8 Billion in Bonuses for Elon as Tesla Shares Hit $1,350]( [Your Guide to Investing in Exchange-Traded Notes (ETNs)]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2020, [Angel Publishing LLC](. All rights reserved. 3 E Read Street Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. ---------------------------------------------------------------